Px Wire

Px Wire is AVAC's quarterly update on biomedical HIV prevention research. Each issue includes a comprehensive timeline of ongoing efficacy trials around the world and a map showing where these trials are happening. Each issue also includes updates on news, emerging issues, and upcoming events.
     

---

PxWire Archive: to view Px Wire issues starting from January 2008

---

January-March 2010, Volume 3, Number 1 (PDF)

Highlights in this issue of Px Wire include updates on:

• The results from MDP 301, a trial of the microbicide PRO 2000, which lay to rest its prospect as a viable microbicide;
• CDC’s newly modified PrEP trial (TDF2 in Botswana), which changed its status as an efficacy trial to a safety and behavioral study;
• The evolving effort to understand the Thai prime-boost AIDS vaccine results;
• Recent NIH grants that nearly double global spending on rectal microbicides; and
• Timeline of 2010 trial milestones—what trial results are   expected and what new studies are scheduled to commence?

Download the updated timeline and map of ongoing efficacy trials around the world:

- Timeline (JPG) or (PDF)
- Map (JPG) or (PDF)